Versatile effects of sildenafil: Recent pharmacological applications

Pharmacological Reports

Volumn 59, Issue 2, 2007, Pages 150-163

  Uthayathas, Subramaniam ^a,b   Karuppagounder, Senthilkumar S ^a   Thrash, Bessy M ^a   Parameshwaran, Kodeeswaran ^a   Suppiramaniam, Vishnu ^a   Dhanasekaran, Muralikrishnan ^a  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF JAFFNA   (Sri Lanka)

Author keywords

Antinociception; Memory enhancement; Neurogenesis; Pulmonary hypertension; Sildenafil

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BETA INTERFERON; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYCLIC GMP DEPENDENT PROTEIN KINASE; DEXFENFLURAMINE; DEXTROMETHORPHAN; FENFLURAMINE; GALANTAMINE; GLATIRAMER; GUANYLATE CYCLASE; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; KETAMINE; MEMANTINE; MITOXANTRONE; MUSCLE RELAXANT AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; OPIATE; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL; VASODILATOR AGENT;

AMNESIA; ATTENTION DISTURBANCE; BLURRED VISION; BURNING SENSATION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; FLUSHING; HEADACHE; HUMAN; LOW DRUG DOSE; MEMORY; MEMORY DISORDER; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; NOSE DISEASE; PAIN; PAINFUL ERECTION; PRURITUS; PULMONARY HYPERTENSION; RESPIRATORY SYSTEM; REVIEW; SEIZURE; SIDE EFFECT; STOMACH DISCOMFORT; SYNCOPE; THORAX PAIN;

EID: 34250778886     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Altman J, Das GD: Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol, 1965, 124, 319-335.
2. Alvarez-Buylla A, Kim, JR, Nottebohm F: Birth of projection neurons in adult avian brain may be related to perceptual or motor learning. Science, 1990, 249, 1444-1446.
3. Ambriz-Tututi M, Velazquez-Zamora DA, Urquiza-Marín H, Granodos-Soto V: Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test. Eur J Pharmacol, 2005, 512, 121-127.
4. Andersson KE: Pharmacology of penile erection. Pharmacol Rev, 2001, 53, 417-450.
5. Araiza-Saldaña CI, Reyes-García G, Bermúdez-Ocaña DY, Perez-Severiano F, Granados-Soto V: Effect of diabetes on the mechanisms of intrathecal aminociception of sildenafil in rats. Eur J Pharmacol, 2005, 527, 60-70.
6. Arancio O, Kandel ER, Hawkins RD: Activity-dependent long-term enhancement of transmitter release by presynaptic 3′, 5′-cyclic GMP in cultured hippocampal neurons. Nature, 1995, 376, 74-80.
7. Argoff CE, Cole BF, Fishbain DA, Irving GA: Diabetic peripheral neuropathic pain: clinical and quality-of-life issues. Mayo Clin Proc, 2006, 81, Suppl 4, S3-11.
8. Asomoza-Espinosa R, Alonso-López R, Mixcoatl-Zecuatl T, Aguirre-Bañuelos P, Torres-López JE, Granados-Soto V: Sildenafil increases diclofenac antinociception in the formalin test. Eur J Pharmacol, 2001, 418, 195-200.
9. Aytac IA, McKinlay JB, Krane RJ: The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int, 1999, 84, 50-56.
10. Baratti CM, Boccia MM: Effects of sildenafil on long-term retention of an inhibitory avoidance response in mice. Behav Pharmacol, 1999, 10, 731-737.
11. Bender AT, Beavo JA: Specific localized expression of cGMP PDEs in Purkinje neurons and macrophages. Neurochem Int, 2004, 45, 853-857.
12. Bernabeu R, Scmitz P, Faillace MP, Izquierdo I, Medina JH: Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning. Neuroreport, 1996, 7, 585-588.
13. Bernabeu R, Schroder N, Quevedo J, Cammaroto M, Izquierdo I, Medina JH: Further evidence for the involvement of a hippocampal cGMP cGMP-dependent protein kinase cascade in memory consolidation. Neuroreport, 1997, 8, 2221-2224.
14. Birks J: Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev, 2006, 25, CD0055593.
15. Blokland A, Schreiber R, Prickaerts J: Improving memory: a role for phosphodiesterases. Curr Pharm Des, 2006, 12, 2511-2523.
16. Bon CL, Garthwaite J: On the role of nitric oxide in hippocampal long-term potentiation. J. Neurosci, 2003, 23, 1941-1948.
17. Boolell M, Allen MJ, Ballard SA, Gepi-Atree S, Muirhead GJ, Naylor AM, Osterloh IH et al.: Sildenafil: an orally active type 5 cGMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. In: J Impot Res, 1996, 8, 47-52.
18. Boulton CL, Southam E, Garthwaite J: Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience, 1995, 69, 699-703.
19. Bremner JD: The relationship between cognitive and brain changes in posttraumatic stress disorder. Ann N Y Acad Sci, 2006, 1071, 80-86.
20. Briganti A, Salonia A, Gallina A, Suardi N, Rigatti P, Montorsi F: Emerging oral drugs for erectile dysfunction. Expert Opin Emerg Drugs, 2004, 9, 179-189.
21. Cameron CA, Gould E: Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience, 1994, 61, 203-209.
22. Cayre M, Strambi C, Charpin P, Augier R, Meyer MR, Edwards JS, Strambi A: Neurogenesis in adult insect mushroom bodies. J Comp Neurol, 1996, 371, 300-310.
23. Chen J, Tu Y, Moon C, Matarazzo V, Palmer AM, Ronett GV: The localization of neuronal nitric oxide synthase may influence its role in neuronal precursor proliferation and synaptic Maintenance. Dev Biol, 2004, 269, 165-182.
24. Corbin JD: Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int J Impot Res, 2004, 16, Suppl 1, S4-7
25. Creeley C, Wozniak DF, Labruyere J, Taylor GT, Olney JW: Low doses of memantine disrupt memory in adult rats. J Neurosci, 2006, 26, 3923-3932.
26. Dean J, de Boer BJ, Graziottin A, Hatzichristou D, Heaton J, Tailor A: Psychological, social, and behavioural benefits for men following effective erectile dysfunction (ED) treatment: men who enjoy better sex experience improved psychological well-being. Eur Urol Suppl, 2006, 5, 773-778.
27. Devan BD, Bowker JL, Duffy KB, Bharati IS, Jimenez M, Sierra-Mereado D Jr, Nelson CM et al.: Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition. Psychopharmacology (Berl), 2006, 183, 439-445.
28. Devan BD, Duffy KB, Bowker JL, Bharati IS, Nelson CM, Daftin Jr LW, Spangler EL, Ingram DK: Phosphodiesterase type 5 (PDE5) inhibition and cognitive enhancement. Drugs of the Future, 2005, 30, 725-736.
29. Devan BD, Sierra-Mercado D Jr, Jimenez M, BowKer JL, Duffy KB, Spangler EL, Ingram DK: Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats. Pharmacol Biochem Behav, 2004, 79, 691-699.
30. Domek-Lopacinska K, Strosznajder JB: cGMP metabolism and its role in brain physiology. J Physiol Pharmacol, 2005, 56, Suppl 2, 15-34.
31. Dundore RL, Clas DM, Wheeler LT, Habeeb PG, Bode DC, Buchholz RA: Zaprinast increases cyclic GMP levels in plasma and in aortic tissues of rats. Eur J Pharmacol, 1993, 249, 293-297.
32. Dundore RL, Habeeb PG, Pratt PF, Becker LT, Clas DM, Buchholz RA: Differential hemodynamic responses to selective inhibitors of cyclic nucleotide phosphodiesterases in conscious rats. J Cardiovasc Pharmacol, 1992, 19, 937-944.
33. Eide K, Stubhaug A, Oye I, Breivik H: Continuous subcutaneous administration of the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain, 1995, 61, 221-228.
34. Erceg S, Monfort P, Hernandez-Viadel M, Rodrigo R, Montoliu C, Felipo V: Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology, 2005, 41, 299-306.
35. Erceg S, Monfort P, Cauli O, Montoliu C, Llansola M, Piedrafita B, Felipo V: Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure: therapeutic implications. Neurochem Int, 2006, 48, 441-446.
36. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH: Neurogenesis in the adult human hippocampus. Nat Med. 1998, 4, 1313-1317.
37. Evans DA, Funkenstein HH, Albert MS: Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA, 1989, 262, 2551-2556.
38. Faria MS, Muscara MN, Moreno JH, Teixeira SA, Dias HB, De Oliveira B, Graeff FG et al.: Acute inhibition of nitric oxide synthesis induces anxiolysis in the Plus maze test. Eur J Pharmacol, 1997, 323, 37-43.
39. Firestein BL, Bredt DS: Regulation of sensory neuron precursor proliferation by cyclic GMP-dependent protein kinase. J Neurochem, 1998, 71, 1846-1853.
40. Galer BS, Gianas A, Jensen MP: Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract, 2000, 47, 123-128.
41. Galluzzi KE: Management of neuropathic pain. J Am Osteopath Assoc, 2005, 105, Suppl, S12-19.
42. Gandolfo C, Sugo A, Del Sette M: Sildenafil and transient global amnesia. Neurol Sci, 2003, 24, 145-146.
43. Ge Y: Multiple sclerosis: the role of MR imaging. AJNR Am J Neuroradiol, 2006, 27, 1165-1176.
44. Geerts H, Grossberg GT: Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease. J Clin Pharmacol, 2006, 46, 8S-16S.
45. Ghofrani HA, Osterloh IH, Grimminger F: Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond, Nat Rev Drug Discov, 2006, 5, 689-702.
46. Gilad R, Lampl Y, Eshel Y, Sadeh M: Tonic-clonic seizures in patients taking sildenafil. BMJ, 2002, 325, 869.
47. Gorkin L, Hvidsten K, Sobel RE, Siegel R: Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy. Int J Clin Pract, 2006, 60, 500-503.
48. Gould E, Reeves AJ, Graziano MSA, Gross CG: Neurogenesis in the neocortex of adult primates. Science, 1999, 286, 549-552.
49. Guazzi M, Tumminello G, Di Marco F, Guazzi MD: Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure. Clin Pharmacol Ther, 2004, 76, 371-378.
50. Harzsch S, Miller J, Benton J, Beltz B: From embryo to adult: persistent neurogenesis and apoptotic cell death shape the lobster deutocerebrum. J Neurosci. 1999, 19, 3472-3485.
51. Hasegawa D, Matsuki N, Fujita M, Ono K, Orima H: Kinetics of glutamate and gamma-aminobutyric acid in cerebrospinal fluid in a canine model of complex partial status epilepticus induced by kainic acid. J Vet Med Sci, 2004, 66, 1555-1559.
52. Hatzimouratidis K, Hatzichristou DG: A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient? Drugs, 2005, 65, 1621-1650.
53. Hawkins RD, Son H, Arancio O: Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. Prog Brain Res, 1998, 118, 155-172.
54. Hayreh SS: Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?. J Neuroophthalmol, 2005, 25, 295-198.
55. Hedelin H, Stroberg P: Treatment for erectile dysfunction based on patient-reported outcomes: to every man the PDE5 inhibitor that he finds superior. Drugs, 2005, 65, 2245-2251.
56. Heese K, Akatsu H: Alzheimer's disease - an interactive perspective. Curr Alzheimer Res, 2006, 3, 109-121.
57. Hinkle J: An update on transient ischemic attacks. J Neurosci Nurs, 2005, 37, 243-248.
58. Hotchkiss AK, Pyter LM, Gatien ML, Wen JC, Milman HA, Nelson RJ: Aggressive behavior increases after termination of chronic sildenafil treatment in mice. Physiol. Behav, 2005, 83, 683-688.
59. Jackson G, Gillies H, Osterlo I: Past present and future: a 7-year update of Viagra ® (Sildenafil citrate). Int J Clin Pract, 2005, 59, 680-691.
60. Jagle H, Jagle C, Serey L, Yu A, Rilk A, Sadowski B, Besch D et al.: Visual short-term effects of Viagra double-blind study in healthy young subjects. Am J Ophthalmol, 2004, 137, 842-849.
61. Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res, 2001, 909, 170-178.
62. Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine. Pharmacology, 2003, 67, 150-156.
63. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H: Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ, 2005, 331, 321-327.
64. Kane LB, Klings ES: Present and future treatment strategies for pulmonary arterial hypertension: focus on phosphodiesterase-5 inhibitors. Treat Respir Med, 2006, 5, 271-282.
65. Kleppisch T, Wolfsgruber W, Feil S, Allmann R, Wotjak CT, Goebbels S, Nave KA et al.: Hippocampal cGMP-dependent protein kinase I supports an age- and protein synthesis-dependent component of long-term potentiation but is not essential for spatial reference and contextual memory. J Neurosci, 2003, 23, 6005-6012.
66. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR et al.: Subanesthetic effect of the noncompetitive NMDA antagonist, ketamine in humans. Psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry, 1994, 51, 199-214.
67. Kurt M, Bilge SS, Aksoz E, Kukula O, Celik S, Kesim Y: Effect of sildenafil on anxiety in the plus-maze test in mice. Pol J Pharmacol, 2004, 56, 353-357.
68. Laties A, Sharlip I: Ocular safety patients using sildenafil citrate therapy for erectile dysfunction. J Sex Med, 2006, 3, 12-27.
69. Lewis ST.: Aetiology of transient global amnesia. Lancet, 1998, 352, 1557-1558.
70. Lledo PM, Alonso M, Grubb MS: Adult neurogenesis and functional plasticity in neuronal circuits. Nat Rev Neurosci. 2006, 7, 179-193.
71. Lois C, Alvarez-Buylla A: Long distance neuronal migration in the adult mammalian brain. Science, 1994, 264, 1145-1148.
72. Malhoιra AK, Pinals DA, Weingartner H, Sirocco K. Missar CD, Pickar D, Breier A: NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology, 1996, 14, 301-307.
73. Manson SC, Burke G, Voets N, Palace J, Matthews PM: Effect of sildenafil citrate on CBF and BOLD activation in multiple sclerosis patients. 21st Congress of the European Committee for the Treatment and Research in Multiple Sclerosis, 2005, Poster No. 237.
74. Mathisen LC, Skjelbred P, Skoglund LA, Oye I: Effect of ketamine, an NMDA receptor inhibitor. in acute and chronic orofacial pain. Pain, 1995, 61, 215-220.
75. McDonald RJ: Multiple combinations of co-factors produce variants of age-related cognitive decline: a theory. Can J Exp Psychol, 2002, 56, 221-239.
76. Milman HA, Arnold SB: Neurologic, psychological, and aggressive disturbances with sildenafil. Ann Pharmacother, 2002, 36, 1129-1134.
77. Monfort P, Munoz MD, Kosenko E, Llansola M, Sanchez-Perez A, Cauli O, Felipo V: Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus: alterations in hyperammonemia. Neurochem Int, 2004, 45, 895-901.
78. Morgan JC, Alhatou M, Oberlies J, Johnston KC: Transient ischemic attack and stroke associated with sildenafil (Viagra) use. Neurology, 2001, 57, 1730-1731.
79. Nurnberg HG: Introduction. Erectile dysfunction and comorbid depression: prevalence, treatment strategies, and associated medical conditions. J Clin Psychiatry, 2003, 64, Suppl 10, 3-4.
80. Ogino Y, Nemoto H, Goto F: Somatotopy in human primary somatosensory cortex in pain system. Anesthesiology, 2005, 103, 821-827.
81. Padma-nathan H, Eardley I, Kloner RA, Laties AM, Montorsi F: A 1-year update on the safety of sildenafil citrate (Viagra). Urology, 2002, 60, 67-90.
82. Paolucci S, Antonucci G, Troisi E, Bragoni M, Coiro P, De Angelis D, Pratesi L et al.: Aging and stroke rehabilitation. A case-comparison study. Cerebrovasc Dis, 2003, 15, 98-105.
83. Patil CS, Singh VP, Kulkarni SK: Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats. Pharmacol Rep, 2006, 58, 373-380.
84. Patil CS, Singh VP, Singh S, Kulkarni SK: Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy. Pharmacology, 2004, 72, 190-195.
85. Patil CS, Jain NK, Singh VP, Kulkarni SK: Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception. Indian J Exp Biol, 2004, 42, 361-367.
86. Pedersen JL, Galle TS, Kehlet H: Peripheral analgesic effects of ketamine in acute inflammatory pain. Anesthesiology, 1998, 89, 58-66.
87. Pezet S, McMahon SB: Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci, 2006, 29, 507-538.
88. Phillips BG, Kato M, Pesek CA, Winnicki M, Narkiewicz K, Davison D, Somers VK: Sympathetic activation by sildenafil. Circulation, 2000, 102, 3068-3073.
89. Phillips W, Michell AW, Barker RA: Neurogenesis in diseases of the central nervous system. Stem Cells Dev, 2006, 15, 359-379.
90. Prickaerts J, Sik A, van der Staay FJ, de Vente J, Blokland A: Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation. Psychopharmacology (Berl), 2005, 177, 381-390
91. Prickaerts J, Sik A, van Staveren WC, Koopmans G, Steinbusch HW, van der Staay FJ, de Vente J et al.: Phosphodiesterase type 5 inhibition improves early memory consolidation of object information. Neurochem Int, 2004, 45, 915-928.
92. Prickaerts J, van Staveren WC, Sik A, Markerink-van Ittersum M, Niewohner U, van der Staay FJ, Blokland A, de Vente J: Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat. Neuroscience, 2002, 113, 351-361.
93. Prickaerts J, de Vente J, Honig W, Steinbusch HW, Blockland A: cGMP, but not CAMP, in rat hippocampus is involved in early stage of object memory consolidation. Eur J Pharmacol, 2002, 436, 83-87.
94. Rashid A: The efficacy and safety of PDE5 inhibitors. Clin Cornerstone, 2005, 7, 47-56.
95. Read S, King M, Watson J: Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med, 1997, 19, 387-391.
96. Reffelmann T, Kloner RA: Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular diease. Cuculador, 2003, 108, 239-244.
97. Reichenberger F, Voswinckei R, Steveling E, Enke B, Kreckel A, Olschewski H, Grimminger F et al.: Sildenafil treatment for portopulmonary hypertension. Eur Respir J, 2006, 28, 563-567.
98. Riazi K, Roshanpour M, Rafiei-Tabatabaei N, Homayoun H, Ebrahimi F, Dehpour AR: The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway Br J Pharmacol, 2006, 147, 935-943.
99. Rieke F, Schwartz EA: A cGW-gated current control exocytosis at synapses. Neuron, 1994, 13, 861-873.
100. Rubin LJ: Primary pulmonary hypertension. N Engl J Med, 1997, 336, 111-117.
101. Rutten K, Vente JD, Sik A, Ittersum MM, Prickaerts J, Blockland A: The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices. Behav Brain Res, 2005, 164, 11-16.
102. Saarto T, Wiffen PJ: Antidepressants for neuropathic pain. Cochrane Database Syst Rev, 2005, 20, CD005454.
103. Sandeman RE, Sandeman DC: "Impoverished" and "Enriched" living conditions influence the proliferation and survival of neurons in crayfish brain. J Neurobiol, 2000, 45, 215-126.
104. Savchenko A, Barnes S, Kramer RH: Cyclic-nucleotidegated Channels mediate synaptic feedback by nitric oxide. Nature, 1997, 390, 694-698.
105. Savitz SA, Caplan L.R: Transient global amenesia after sildenafil (Viagra) use. Neurology, 2002, 59, 778.
106. Schmidt M: Neuronal differentiation and long-term survival of newly generated cells in the olfactory mid-brain of the adult spiny lobster. Panulirus argus. J Neurobiol, 2001, 48, 181-203.
107. Schultheiss D, Muller SV, Nager W, Stief CG, Schlote N, Jonas U, Asvestis C et al.: Central effcets of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials. World J Urol, 2001, 19, 46-50.
108. Selig DK, Segal MR, Liao D, Malenka RC, Malinow R, Nicoll RA, Lisman JE: Examination of the role of cGMP in long-term potentiation in the CA1 region of the hippocampus. Learn Mem, 1996, 3.,42-48.
109. Shamloul R. Management or honeymoon impotence. J Sex Med, 2006, 3, 361-366.
110. Sills T, Wunderlich G, Pyke R, Segraves T, Leiblum S, Clayton A, Cotton D et al.: The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder. J. Sex Med, 2005, 2, 801-818.
111. Singh N, Parie M: Sildenafil improves acquisition and retention of memory in mice. Indian J Physiol Pharmacol, 2003, 47, 318-324.
112. Sommer F, Schulze W: Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors. World J Urol, 2005, 23, 385-392
113. Steidle CP, Stecher VJ, Pace C, Tseng LJ: The SEAR Study Group. Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the self-esteem and relationship questionnaire in men treated with sildenafil for erecitile dysfunction and stratified by age. Curr Med Res Opin, 2006, 22, 939-1448.
114. Suzuki M, Nelson AD, Eickstaedt JB, Wallace K, Wright LS, Svendsen CN: Glutamate enhances proliferation and neurogenesis in human neural progenitor cell cultures derived from the fetal cortex. Eur J Neurosci, 2006, 24, 645-651.
115. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A: Age-related reduction of NO availability and oxidative stress in humans. Hypertension, 2001, 38, 274-279.
116. Taupin P: Neurogenesis in the adult central nervous system. C R Biol, 2006, 69, 465-475.
117. Taupin P, Gage FH: Adult neurogenesis and neural stem cells of the central nervous system in mammals. J Neurosci Res, 2002, 69, 745-749.
118. Tharakan B, Manyam BV: Botanical therapies in sexual dysfunction. Phytother Res, 2005, 19, 457-463.
119. Turko IV, Ballard SA, Francis SH, Corbin JD: Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (type 5 ) by sildenafil and related compounds, Mol Pharmacol, 1999, 56, 124-130.
120. Van der Kooy D: Adult mammalian forebrain ependymal and Subependymal cells demonstrate proliferative Potential, but only subependymal cells have neural stem cell characteristics. J Neuroci, 1999, 19, 4462-4471.
121. Volke V, Wegener G, Vasar E: Augmentation of the NO-cGMP cascade induces anxiogenic-like effect in mice. J Naysiol Pharmacol, 2003, 54, 653-660.
122. Wang L, Gang Zhang Z,. Lan Zhang R, Chopp M: Activation of he PI3-K Akt pathway mediates cGMP enhanced-neurogenesis in the adult progenitor cells derived from the subventricular zone. J Cerebr Blood Flow Metab, 2005, 25, 1150-1158.
123. Wati H, Kudo K, Qiao C, Kuroki T, Kanba S: A decreased survival of proliferated cells in the hippocampus is associated with a decline in spatial memory in aged rats. Neurosci Lett, 2006, 399, 171-174.
124. Wiesenfeld-Hallin Z: Combined opioid. NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes? Drugs, 1998, 55, 1-4.
125. Yoon MH, Chot JI, Bae HB, Jeong SW, Chung SS,. Yoo KY, Jeonq CY et al.: Lack of the nitric oxide-cyclic GMP-potassium channel pathway for the antinociceptive effect of intrathecal zaprinast in a rat formalin test. Neurosci Lett, 2005, 23, 390, 114-117.
126. Zhang RL, Zhang Z, Zhang L, Wang Y, Zhang C, Chopp M: Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia. J Neurosci Res, 2006, 83, 1213-1219.
127. Zhang L, Zhang RL, Wang Y, Zhang C, Zhang ZG, Meng H, Chopp M: Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke, 2005, 36, 847-852.
128. Zhang R, Wang Y, Zhang L, Zhang Z, Tsang W, Lu M, Zhang L et al.: Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke, 2002, 33, 2675-2680.